Anti-platelets

The Short-Term Aggrastat Infusion Registry (STAIR): Evaluating the Safety and Efficacy of Heparin + Short-Term Tirofiban vs Bivalirudin in PCI

09/05/2019

Cath Lab Digest talks with J. Brent Muhlestein, MD, FAHA, FACC,
Co-Director of Cardiology Research, Intermountain Health Care and
Intermountain Medical Center, Salt Lake City, Utah; Professor of Medicine, University of Utah, Salt Lake City, Utah.

Cath Lab Digest talks with J. Brent M...

We compared patients with coronary artery disease who underwent PCI having received either scheduled, planned tirofiban with short-term infusion or planned bivalirudin, which most of the time was without any use of a GP IIb/IIIa receptor...

We compared patients with...

09/05/2019

Cath Lab Digest

Strategies to Circumvent the Delayed Mechanism of Action of Oral Antiplatelets in the Cardiac Catheterization Lab

02/03/2019

Cath Lab Digest talks with Mahir Elder, MD, Clinical Professor at Wayne State University School of Medicine, Detroit, Michigan; Clinical Professor at Michigan State University College of Osteopathic Medicine, East Lansing, Michigan.

Cath Lab Digest talks with Mahir Elde...

The ongoing opioid crisis in this country, along with the judicial use of morphine in patients with acute coronary syndrome, have created an environment where it is important to bring awareness to physicians and medical staff about morphine,...

The ongoing opioid crisis in...

02/03/2019

Cath Lab Digest